APOE2 Confers Atheroprotection, Especially to Young Adults
Genetic testing for APOE would improve the prediction of atherosclerosis and enable the pursuit of aggressive strategies, said one researcher.
Stay updated with breaking news from Marta Cort. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetic testing for APOE would improve the prediction of atherosclerosis and enable the pursuit of aggressive strategies, said one researcher.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares in Madrid have found that one of the most potent genetic risk factors for Alzheimer disease, apolipoprotein E4 (APOE4), is also associated with an increased risk of developing subclinical atherosclerosis in middle age.
Heart health may influence long-term brain health as early as middle age.
Cardiovascular disease and dementia frequently occur together in elderly people. Nevertheless, few longitudinal studies have examined how atherosclerosis and its associated risk factors affect brain health from middle age.
E-Mail IMAGE: 3D reconstructions of superior (left) and inferior (right) brain regions, showing regions with lower metabolism associated with the presence of atherosclerotic plaques in the carotid arteries. The color code indicates... view more Credit: CNIC The links between cardiovascular disease and cognitive impairment begin years before the appearance of the first clinical symptoms of either condition. In a study carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in partnership with Santander Bank and neuroimaging experts at the Barcelonaβeta Brain ...